Featured In

Federation of European Neuroscience Societies (FENS) · Forum 2026, Barcelona · June 2026 — "Mohn Research Center for Psychotic Disorders, Haukeland University Hospital"

A short film introducing our research home in Bergen, where stem-cell and genetic tools are used to understand psychotic disorders and move toward precision treatment.

Mohn Research Center for Psychotic Disorders (MRCP) at Haukeland University Hospital

Psychotic disorders affect millions of people worldwide, yet patients with similar symptoms can respond very differently to the same treatments. Researchers at the Mohn Research Center for Psychotic Disorders (MRCP) at Haukeland University Hospital are working to uncover why. By combining clinical expertise, patient perspectives, stem cell technology, and cutting-edge neuroscience, the team is investigating the biological mechanisms that drive psychosis at an individual level. Using patient-derived neurons and brain organoids, they are moving beyond symptom-based approaches toward a future of precision psychiatry—where treatments are tailored to the underlying causes of disease. Featuring researchers, clinicians, and lived experience advocates, this film explores how a deeper understanding of brain biology could transform the diagnosis and treatment of psychotic disorders. The collaboration and scientific projects are made possible by the Trond Mohn Research Foundation (MRCRM and MRCP), and the Research Council of Norway.  The research is being conducted at Bergen Psychosis Research Group, Gene to Circuit lab, Psykoseforsking med erfaringskompetanse, the Ex vivo and Pre-GMP laboratories, and Bergen Center for Medical Stem Cell Research. The center is a joint initiative from Division of Psychiatry, Haukeland University Hospital and the Departments of Clinical Medicine 1 and Biomedicine, University of Bergen. Haukeland University Hospital: https://www.helse-bergen.no/en/steder/haukeland University of Bergen: https://www4.uib.no/en

youtu.be

Science Norway (sciencenorway.no)· May 2026

"How one genetic error can affect both the heart and the brain"

Why do so many children with neurodevelopmental disorders also have heart defects? Our work uses CRISPR and stem cells to show how a single broken gene can damage both organs.

Yale News · May 2026

"Many genes have been linked to autism, but a new study suggests it may be their path to the brain that matters"

Hundreds of autism-linked genes turn out to funnel into the same brain pathways — synapses, gene regulation, and cellular energy — raising the hope that one treatment could reach many genetic causes at once.

Many genes have been linked to autism – but a new study suggests it may be their path to the brain that matters

While scientists have identified hundreds of different genes that are associated with autism, a new Yale-led study suggests that the specific genes may be less important than the pathway they take to the brain.

news.yale.edu

Helse Bergen · Research News · Apr 2026

"Researchers at Haukeland behind a new breakthrough in brain research"

Our Nature Neuroscience study showing that 29 genetically different autism and developmental-delay risk genes converge on the same pathways in brain neurons — and, unexpectedly, on the cell's energy machinery, opening a new route to treatment.

Forskarar ved Haukeland står bak nytt gjennombrot i hjerneforsking

Korleis kan mange ulike genetiske risikofaktorar føre til dei same nevrologiske sjukdomane? Eit nytt forskingsarbeid, der to forskarar frå Helse Bergen har samarbeidd med Yale University, gir no viktige svar. Studien er nyleg publisert i Nature Neuroscience, eitt av verdas mest anerkjende vitskaplege tidsskrift.

www.helse-bergen.no

Helse Bergen · Regenerative Medicine · Apr 2024

"Make strides in precision medicine using hiPSCs"

How we use patient-derived stem cells and CRISPR screens to uncover why antipsychotic drugs work for some people and not others — and the plan to bring this research home to Berge

Make strides in precision medicine using hiPSCs

Read the interview with Dr. Novin Balafkan and Dr. Sadaf Ghorbani in "NBS nytt" 04-2023. The visiting researchers from Norway, are engaged in a groundbreaking precision medicine project for neuropsychiatric disorders at Yale University.

www.helse-bergen.no